OBSP Spike Level Charts

BQS OBSP Determination:

1,7-DIMETHYLXANTHINE (P-XANTHINE)

METHOD: 2440 , TESTIDCODE: 67446LCM56

Plotted Points Statistics

1,7-DIMETHYLXANTHINE (P-XANTHINE)

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	34	103%	23%	101%	29%
Total	34	103%	23%	101%	29%

Sample Statistics

1,7-DIMETHYLXANTHINE (P-XANTHINE)

Characteristic	N	%	% Basis
Plotted	34	97%	Spiked
Estimated Values	3	9%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	35	.
False Negatives	1	3%	1 out of 35
Not Spiked	17	.
False Positives	0	0%	0 out of 17

BQS OBSP Determination:

10-HYDROXY-AMITRIPTYLINE

METHOD: 2440 , TESTIDCODE: 67995LCM56

Open Data Set

Plotted Points Statistics

10-HYDROXY-AMITRIPTYLINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	22	61%	28%	56%	16%
Total	22	61%	28%	56%	16%

Sample Statistics

10-HYDROXY-AMITRIPTYLINE

Characteristic	N	%	% Basis
Plotted	22	100%	Spiked
Estimated Values	17	77%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	22	.
False Negatives	0	0%	0 out of 22
Not Spiked	30	.
False Positives	0	0%	0 out of 30

BQS OBSP Determination:

ABACAVIR

METHOD: 2440 , TESTIDCODE: 68022LCM56

Open Data Set

Plotted Points Statistics

ABACAVIR

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	33	60%	8%	59%	6%
Total	33	60%	8%	59%	6%

Sample Statistics

ABACAVIR

Characteristic	N	%	% Basis
Plotted	33	100%	Spiked
Estimated Values	0	0%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	33	.
False Negatives	0	0%	0 out of 33
Not Spiked	19	.
False Positives	0	0%	0 out of 19

BQS OBSP Determination:

ACETAMINOPHEN

METHOD: 2440 , TESTIDCODE: 67436LCM56

Open Data Set

Plotted Points Statistics

ACETAMINOPHEN

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	30	100%	120%	77%	23%
Total	30	100%	120%	77%	23%

Sample Statistics

ACETAMINOPHEN

Characteristic	N	%	% Basis
Plotted	30	88%	Spiked
Estimated Values	4	12%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	1	3%	Spiked
Spiked	34	.
False Negatives	3	9%	3 out of 34
Not Spiked	18	.
False Positives	0	0%	0 out of 18

BQS OBSP Determination:

ACYCLOVIR

METHOD: 2440 , TESTIDCODE: 67484LCM56

Open Data Set

Plotted Points Statistics

ACYCLOVIR

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	31	169%	127%	142%	169%
Total	31	169%	127%	142%	169%

Sample Statistics

ACYCLOVIR

Characteristic	N	%	% Basis
Plotted	31	94%	Spiked
Estimated Values	2	6%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	2	6%	Spiked
Spiked	33	.
False Negatives	0	0%	0 out of 33
Not Spiked	19	.
False Positives	13	68%	13 out of 19

BQS OBSP Determination:

ALBUTEROL (SALBUTAMOL)

METHOD: 2440 , TESTIDCODE: 67437LCM56

Open Data Set

Plotted Points Statistics

ALBUTEROL (SALBUTAMOL)

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	34	75%	19%	80%	18%
Total	34	75%	19%	80%	18%

Sample Statistics

ALBUTEROL (SALBUTAMOL)

Characteristic	N	%	% Basis
Plotted	34	100%	Spiked
Estimated Values	8	24%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	34	.
False Negatives	0	0%	0 out of 34
Not Spiked	18	.
False Positives	0	0%	0 out of 18

BQS OBSP Determination:

ALPRAZOLAM

METHOD: 2440 , TESTIDCODE: 68250LCM56

Open Data Set

Plotted Points Statistics

ALPRAZOLAM

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	18	81%	16%	81%	13%
Total	18	81%	16%	81%	13%

Sample Statistics

ALPRAZOLAM

Characteristic	N	%	% Basis
Plotted	18	95%	Spiked
Estimated Values	6	32%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	19	.
False Negatives	1	5%	1 out of 19
Not Spiked	33	.
False Positives	3	9%	3 out of 33

BQS OBSP Determination:

AMITRIPTYLINE

METHOD: 2440 , TESTIDCODE: 67522LCM56

Open Data Set

Plotted Points Statistics

AMITRIPTYLINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	33	50%	13%	52%	11%
Total	33	50%	13%	52%	11%

Sample Statistics

AMITRIPTYLINE

Characteristic	N	%	% Basis
Plotted	33	100%	Spiked
Estimated Values	33	100%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	33	.
False Negatives	0	0%	0 out of 33
Not Spiked	19	.
False Positives	0	0%	0 out of 19

BQS OBSP Determination:

AMPHETAMINE

METHOD: 2440 , TESTIDCODE: 67461LCM56

Open Data Set

Plotted Points Statistics

AMPHETAMINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	20	73%	10%	73%	8%
Total	20	73%	10%	73%	8%

Sample Statistics

AMPHETAMINE

Characteristic	N	%	% Basis
Plotted	20	100%	Spiked
Estimated Values	9	45%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	20	.
False Negatives	0	0%	0 out of 20
Not Spiked	32	.
False Positives	0	0%	0 out of 32

BQS OBSP Determination:

ANTIPYRENE

METHOD: 2440 , TESTIDCODE: 67477LCM56

Open Data Set

Plotted Points Statistics

ANTIPYRENE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	34	80%	12%	80%	11%
Total	34	80%	12%	80%	11%

Sample Statistics

ANTIPYRENE

Characteristic	N	%	% Basis
Plotted	34	100%	Spiked
Estimated Values	1	3%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	34	.
False Negatives	0	0%	0 out of 34
Not Spiked	18	.
False Positives	0	0%	0 out of 18

BQS OBSP Determination:

ATENOLOL

METHOD: 2440 , TESTIDCODE: 67502LCM56

Open Data Set

Plotted Points Statistics

ATENOLOL

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	24	75%	14%	75%	12%
Total	24	75%	14%	75%	12%

Sample Statistics

ATENOLOL

Characteristic	N	%	% Basis
Plotted	24	71%	Spiked
Estimated Values	3	9%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	3	9%	Spiked
Spiked	34	.
False Negatives	7	21%	7 out of 34
Not Spiked	18	.
False Positives	0	0%	0 out of 18

BQS OBSP Determination:

ATRAZINE

METHOD: 2440 , TESTIDCODE: 65065LCM56

Open Data Set

Plotted Points Statistics

ATRAZINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	34	78%	13%	77%	11%
Total	34	78%	13%	77%	11%

Sample Statistics

ATRAZINE

Characteristic	N	%	% Basis
Plotted	34	97%	Spiked
Estimated Values	0	0%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	35	.
False Negatives	1	3%	1 out of 35
Not Spiked	17	.
False Positives	0	0%	0 out of 17

BQS OBSP Determination:

BENZTROPINE

METHOD: 2440 , TESTIDCODE: 67997LCM56

Open Data Set

Plotted Points Statistics

BENZTROPINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	19	55%	24%	50%	16%
Total	19	55%	24%	50%	16%

Sample Statistics

BENZTROPINE

Characteristic	N	%	% Basis
Plotted	19	56%	Spiked
Estimated Values	19	56%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	34	.
False Negatives	15	44%	15 out of 34
Not Spiked	18	.
False Positives	0	0%	0 out of 18

BQS OBSP Determination:

BETAMETHASONE

METHOD: 2440 , TESTIDCODE: 67485LCM56

Open Data Set

Plotted Points Statistics

BETAMETHASONE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	34	93%	17%	94%	20%
Total	34	93%	17%	94%	20%

Sample Statistics

BETAMETHASONE

Characteristic	N	%	% Basis
Plotted	34	100%	Spiked
Estimated Values	8	24%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	34	.
False Negatives	0	0%	0 out of 34
Not Spiked	18	.
False Positives	0	0%	0 out of 18

BQS OBSP Determination:

BUPROPION

METHOD: 2440 , TESTIDCODE: 67439LCM56

Open Data Set

Plotted Points Statistics

BUPROPION

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	35	70%	14%	69%	16%
Total	35	70%	14%	69%	16%

Sample Statistics

BUPROPION

Characteristic	N	%	% Basis
Plotted	35	100%	Spiked
Estimated Values	1	3%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	35	.
False Negatives	0	0%	0 out of 35
Not Spiked	17	.
False Positives	0	0%	0 out of 17

BQS OBSP Determination:

CAFFEINE

METHOD: 2440 , TESTIDCODE: 67440LCM56

Open Data Set

Plotted Points Statistics

CAFFEINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	33	79%	22%	76%	11%
Total	33	79%	22%	76%	11%

Sample Statistics

CAFFEINE

Characteristic	N	%	% Basis
Plotted	33	97%	Spiked
Estimated Values	10	29%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	1	3%	Spiked
Spiked	34	.
False Negatives	0	0%	0 out of 34
Not Spiked	18	.
False Positives	2	11%	2 out of 18

BQS OBSP Determination:

CARBAMAZEPINE

METHOD: 2440 , TESTIDCODE: 67441LCM56

Open Data Set

Plotted Points Statistics

CARBAMAZEPINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
< Reporting Level	14	69%	11%	71%	12%
>= Reporting Level	23	77%	11%	76%	12%
Total	37	74%	12%	74%	8%

Sample Statistics

CARBAMAZEPINE

Characteristic	N	%	% Basis
Plotted	37	100%	Spiked
Estimated Values	1	3%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	37	.
False Negatives	0	0%	0 out of 37
Not Spiked	15	.
False Positives	0	0%	0 out of 15

BQS OBSP Determination:

CARISOPRODOL

METHOD: 2440 , TESTIDCODE: 67498LCM56

Open Data Set

Plotted Points Statistics

CARISOPRODOL

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	31	73%	12%	72%	14%
Total	31	73%	12%	72%	14%

Sample Statistics

CARISOPRODOL

Characteristic	N	%	% Basis
Plotted	31	97%	Spiked
Estimated Values	5	16%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	32	.
False Negatives	1	3%	1 out of 32
Not Spiked	20	.
False Positives	1	5%	1 out of 20

BQS OBSP Determination:

CHLORPHENIRAMINE

METHOD: 2440 , TESTIDCODE: 67497LCM56

Open Data Set

Plotted Points Statistics

CHLORPHENIRAMINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	20	42%	13%	40%	12%
Total	20	42%	13%	40%	12%

Sample Statistics

CHLORPHENIRAMINE

Characteristic	N	%	% Basis
Plotted	20	65%	Spiked
Estimated Values	6	19%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	31	.
False Negatives	11	35%	11 out of 31
Not Spiked	21	.
False Positives	0	0%	0 out of 21

BQS OBSP Determination:

CIMETIDINE

METHOD: 2440 , TESTIDCODE: 67442LCM56

Open Data Set

Plotted Points Statistics

CIMETIDINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	14	58%	22%	62%	21%
Total	14	58%	22%	62%	21%

Sample Statistics

CIMETIDINE

Characteristic	N	%	% Basis
Plotted	14	39%	Spiked
Estimated Values	14	39%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	3	8%	Spiked
Spiked	36	.
False Negatives	19	53%	19 out of 36
Not Spiked	16	.
False Positives	0	0%	0 out of 16

BQS OBSP Determination:

CITALOPRAM

METHOD: 2440 , TESTIDCODE: 67505LCM56

Open Data Set

Plotted Points Statistics

CITALOPRAM

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	27	50%	25%	45%	17%
Total	27	50%	25%	45%	17%

Sample Statistics

CITALOPRAM

Characteristic	N	%	% Basis
Plotted	27	82%	Spiked
Estimated Values	6	18%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	1	3%	Spiked
Spiked	33	.
False Negatives	5	15%	5 out of 33
Not Spiked	19	.
False Positives	0	0%	0 out of 19

BQS OBSP Determination:

CLONIDINE

METHOD: 2440 , TESTIDCODE: 67518LCM56

Open Data Set

Plotted Points Statistics

CLONIDINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	34	82%	12%	83%	10%
Total	34	82%	12%	83%	10%

Sample Statistics

CLONIDINE

Characteristic	N	%	% Basis
Plotted	34	100%	Spiked
Estimated Values	2	6%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	34	.
False Negatives	0	0%	0 out of 34
Not Spiked	18	.
False Positives	0	0%	0 out of 18

BQS OBSP Determination:

CODEINE

METHOD: 2440 , TESTIDCODE: 67443LCM56

Open Data Set

Plotted Points Statistics

CODEINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	18	76%	14%	74%	16%
Total	18	76%	14%	74%	16%

Sample Statistics

CODEINE

Characteristic	N	%	% Basis
Plotted	18	100%	Spiked
Estimated Values	4	22%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	18	.
False Negatives	0	0%	0 out of 18
Not Spiked	34	.
False Positives	0	0%	0 out of 34

BQS OBSP Determination:

COTININE

METHOD: 2440 , TESTIDCODE: 67444LCM56

Open Data Set

Plotted Points Statistics

COTININE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	30	80%	14%	80%	16%
Total	30	80%	14%	80%	16%

Sample Statistics

COTININE

Characteristic	N	%	% Basis
Plotted	30	88%	Spiked
Estimated Values	7	21%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	34	.
False Negatives	4	12%	4 out of 34
Not Spiked	18	.
False Positives	2	11%	2 out of 18

BQS OBSP Determination:

DEHYDRONIFEDIPINE

METHOD: 2440 , TESTIDCODE: 67445LCM56

Open Data Set

Plotted Points Statistics

DEHYDRONIFEDIPINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	34	76%	14%	75%	6%
Total	34	76%	14%	75%	6%

Sample Statistics

DEHYDRONIFEDIPINE

Characteristic	N	%	% Basis
Plotted	34	97%	Spiked
Estimated Values	9	26%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	35	.
False Negatives	1	3%	1 out of 35
Not Spiked	17	.
False Positives	0	0%	0 out of 17

BQS OBSP Determination:

DESMETHYLDILTIAZEM

METHOD: 2440 , TESTIDCODE: 67999LCM56

Open Data Set

Plotted Points Statistics

DESMETHYLDILTIAZEM

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	24	39%	16%	38%	15%
Total	24	39%	16%	38%	15%

Sample Statistics

DESMETHYLDILTIAZEM

Characteristic	N	%	% Basis
Plotted	24	73%	Spiked
Estimated Values	24	73%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	33	.
False Negatives	9	27%	9 out of 33
Not Spiked	19	.
False Positives	0	0%	0 out of 19

BQS OBSP Determination:

DESVENLAFAXINE

METHOD: 2440 , TESTIDCODE: 68251LCM56

Open Data Set

Plotted Points Statistics

DESVENLAFAXINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	32	70%	13%	69%	14%
Total	32	70%	13%	69%	14%

Sample Statistics

DESVENLAFAXINE

Characteristic	N	%	% Basis
Plotted	32	94%	Spiked
Estimated Values	8	24%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	1	3%	Spiked
Spiked	34	.
False Negatives	1	3%	1 out of 34
Not Spiked	18	.
False Positives	0	0%	0 out of 18

BQS OBSP Determination:

DEXTROMETHORPHAN

METHOD: 2440 , TESTIDCODE: 67468LCM56

Open Data Set

Plotted Points Statistics

DEXTROMETHORPHAN

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	34	63%	13%	65%	13%
Total	34	63%	13%	65%	13%

Sample Statistics

DEXTROMETHORPHAN

Characteristic	N	%	% Basis
Plotted	34	100%	Spiked
Estimated Values	1	3%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	34	.
False Negatives	0	0%	0 out of 34
Not Spiked	18	.
False Positives	1	6%	1 out of 18

BQS OBSP Determination:

DIAZEPAM (VALIUM)

METHOD: 2440 , TESTIDCODE: 67499LCM56

Open Data Set

Plotted Points Statistics

DIAZEPAM (VALIUM)

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	20	72%	21%	68%	20%
Total	20	72%	21%	68%	20%

Sample Statistics

DIAZEPAM (VALIUM)

Characteristic	N	%	% Basis
Plotted	20	91%	Spiked
Estimated Values	0	0%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	1	5%	Spiked
Spiked	22	.
False Negatives	1	5%	1 out of 22
Not Spiked	30	.
False Positives	0	0%	0 out of 30

BQS OBSP Determination:

DILTIAZEM

METHOD: 2440 , TESTIDCODE: 67519LCM56

Open Data Set

Plotted Points Statistics

DILTIAZEM

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	26	49%	11%	52%	12%
Total	26	49%	11%	52%	12%

Sample Statistics

DILTIAZEM

Characteristic	N	%	% Basis
Plotted	26	79%	Spiked
Estimated Values	3	9%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	33	.
False Negatives	7	21%	7 out of 33
Not Spiked	19	.
False Positives	0	0%	0 out of 19

BQS OBSP Determination:

DIPHENHYDRAMINE

METHOD: 2440 , TESTIDCODE: 67447LCM56

Open Data Set

Plotted Points Statistics

DIPHENHYDRAMINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	30	67%	10%	66%	8%
Total	30	67%	10%	66%	8%

Sample Statistics

DIPHENHYDRAMINE

Characteristic	N	%	% Basis
Plotted	30	86%	Spiked
Estimated Values	8	23%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	1	3%	Spiked
Spiked	35	.
False Negatives	4	11%	4 out of 35
Not Spiked	17	.
False Positives	0	0%	0 out of 17

BQS OBSP Determination:

DULOXETINE

METHOD: 2440 , TESTIDCODE: 67448LCM56

Open Data Set

Plotted Points Statistics

DULOXETINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	32	52%	17%	53%	11%
Total	32	52%	17%	53%	11%

Sample Statistics

DULOXETINE

Characteristic	N	%	% Basis
Plotted	32	91%	Spiked
Estimated Values	32	91%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	35	.
False Negatives	3	9%	3 out of 35
Not Spiked	17	.
False Positives	0	0%	0 out of 17

BQS OBSP Determination:

ERYTHROMYCIN

METHOD: 2440 , TESTIDCODE: 67449LCM56

Open Data Set

Plotted Points Statistics

ERYTHROMYCIN

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	22	43%	14%	47%	14%
Total	22	43%	14%	47%	14%

Sample Statistics

ERYTHROMYCIN

Characteristic	N	%	% Basis
Plotted	22	67%	Spiked
Estimated Values	4	12%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	1	3%	Spiked
Spiked	33	.
False Negatives	10	30%	10 out of 33
Not Spiked	19	.
False Positives	0	0%	0 out of 19

BQS OBSP Determination:

EZETIMIBE

METHOD: 2440 , TESTIDCODE: 67487LCM56

Open Data Set

Plotted Points Statistics

EZETIMIBE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	19	65%	59%	42%	35%
Total	19	65%	59%	42%	35%

Sample Statistics

EZETIMIBE

Characteristic	N	%	% Basis
Plotted	19	54%	Spiked
Estimated Values	19	54%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	3	9%	Spiked
Spiked	35	.
False Negatives	13	37%	13 out of 35
Not Spiked	17	.
False Positives	0	0%	0 out of 17

BQS OBSP Determination:

FADROZOLE

METHOD: 2440 , TESTIDCODE: 68012LCM56

Open Data Set

Plotted Points Statistics

FADROZOLE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	32	66%	11%	65%	10%
Total	32	66%	11%	65%	10%

Sample Statistics

FADROZOLE

Characteristic	N	%	% Basis
Plotted	32	97%	Spiked
Estimated Values	1	3%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	33	.
False Negatives	1	3%	1 out of 33
Not Spiked	19	.
False Positives	2	11%	2 out of 19

BQS OBSP Determination:

FAMOTIDINE

METHOD: 2440 , TESTIDCODE: 68000LCM56

Open Data Set

Plotted Points Statistics

FAMOTIDINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	18	89%	64%	62%	29%
Total	18	89%	64%	62%	29%

Sample Statistics

FAMOTIDINE

Characteristic	N	%	% Basis
Plotted	18	53%	Spiked
Estimated Values	18	53%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	5	15%	Spiked
Spiked	34	.
False Negatives	11	32%	11 out of 34
Not Spiked	18	.
False Positives	0	0%	0 out of 18

BQS OBSP Determination:

FENOFIBRATE

METHOD: 2440 , TESTIDCODE: 67489LCM56

Open Data Set

Plotted Points Statistics

FENOFIBRATE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	20	49%	21%	47%	20%
Total	20	49%	21%	47%	20%

Sample Statistics

FENOFIBRATE

Characteristic	N	%	% Basis
Plotted	20	54%	Spiked
Estimated Values	8	22%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	1	3%	Spiked
Spiked	37	.
False Negatives	16	43%	16 out of 37
Not Spiked	16	.
False Positives	0	0%	0 out of 16

BQS OBSP Determination:

FEXOFENADINE

METHOD: 2440 , TESTIDCODE: 67510LCM56

Open Data Set

Plotted Points Statistics

FEXOFENADINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	32	61%	9%	60%	8%
Total	32	61%	9%	60%	8%

Sample Statistics

FEXOFENADINE

Characteristic	N	%	% Basis
Plotted	32	94%	Spiked
Estimated Values	7	21%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	34	.
False Negatives	2	6%	2 out of 34
Not Spiked	18	.
False Positives	0	0%	0 out of 18

BQS OBSP Determination:

FLUCONAZOLE

METHOD: 2440 , TESTIDCODE: 67478LCM56

Open Data Set

Plotted Points Statistics

FLUCONAZOLE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	32	88%	17%	92%	14%
Total	32	88%	17%	92%	14%

Sample Statistics

FLUCONAZOLE

Characteristic	N	%	% Basis
Plotted	32	97%	Spiked
Estimated Values	4	12%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	33	.
False Negatives	1	3%	1 out of 33
Not Spiked	19	.
False Positives	0	0%	0 out of 19

BQS OBSP Determination:

FLUOXETINE

METHOD: 2440 , TESTIDCODE: 67450LCM56

Open Data Set

Plotted Points Statistics

FLUOXETINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	31	58%	12%	54%	13%
Total	31	58%	12%	54%	13%

Sample Statistics

FLUOXETINE

Characteristic	N	%	% Basis
Plotted	31	91%	Spiked
Estimated Values	31	91%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	34	.
False Negatives	3	9%	3 out of 34
Not Spiked	18	.
False Positives	0	0%	0 out of 18

BQS OBSP Determination:

FLUTICASONE PROPIONATE

METHOD: 2440 , TESTIDCODE: 67529LCM56

Open Data Set

Plotted Points Statistics

FLUTICASONE PROPIONATE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	30	71%	23%	69%	22%
Total	30	71%	23%	69%	22%

Sample Statistics

FLUTICASONE PROPIONATE

Characteristic	N	%	% Basis
Plotted	30	91%	Spiked
Estimated Values	9	27%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	33	.
False Negatives	3	9%	3 out of 33
Not Spiked	19	.
False Positives	0	0%	0 out of 19

BQS OBSP Determination:

FLUVOXAMINE

METHOD: 2440 , TESTIDCODE: 67521LCM56

Open Data Set

Plotted Points Statistics

FLUVOXAMINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	33	41%	14%	43%	12%
Total	33	41%	14%	43%	12%

Sample Statistics

FLUVOXAMINE

Characteristic	N	%	% Basis
Plotted	33	94%	Spiked
Estimated Values	33	94%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	35	.
False Negatives	2	6%	2 out of 35
Not Spiked	18	.
False Positives	0	0%	0 out of 18

BQS OBSP Determination:

GLIPIZIDE

METHOD: 2440 , TESTIDCODE: 68001LCM56

Open Data Set

Plotted Points Statistics

GLIPIZIDE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
< Reporting Level	1	94%	.	94%	0%
>= Reporting Level	9	90%	27%	97%	10%
Total	10	90%	26%	95%	10%

Sample Statistics

GLIPIZIDE

Characteristic	N	%	% Basis
Plotted	10	30%	Spiked
Estimated Values	9	27%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	23	70%	Spiked
Spiked	33	.
False Negatives	0	0%	0 out of 33
Not Spiked	19	.
False Positives	0	0%	0 out of 19

BQS OBSP Determination:

GLYBURIDE

METHOD: 2440 , TESTIDCODE: 68002LCM56

Open Data Set

Plotted Points Statistics

GLYBURIDE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	31	68%	19%	72%	15%
Total	31	68%	19%	72%	15%

Sample Statistics

GLYBURIDE

Characteristic	N	%	% Basis
Plotted	31	91%	Spiked
Estimated Values	9	26%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	34	.
False Negatives	3	9%	3 out of 34
Not Spiked	18	.
False Positives	0	0%	0 out of 18

BQS OBSP Determination:

HYDROCODONE

METHOD: 2440 , TESTIDCODE: 67506LCM56

Open Data Set

Plotted Points Statistics

HYDROCODONE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	15	76%	21%	77%	18%
Total	15	76%	21%	77%	18%

Sample Statistics

HYDROCODONE

Characteristic	N	%	% Basis
Plotted	15	83%	Spiked
Estimated Values	3	17%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	18	.
False Negatives	3	17%	3 out of 18
Not Spiked	34	.
False Positives	0	0%	0 out of 34

BQS OBSP Determination:

HYDROCORTISONE

METHOD: 2440 , TESTIDCODE: 67459LCM56

Open Data Set

Plotted Points Statistics

HYDROCORTISONE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	30	85%	13%	86%	12%
Total	30	85%	13%	86%	12%

Sample Statistics

HYDROCORTISONE

Characteristic	N	%	% Basis
Plotted	30	91%	Spiked
Estimated Values	9	27%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	33	.
False Negatives	3	9%	3 out of 33
Not Spiked	19	.
False Positives	0	0%	0 out of 19

BQS OBSP Determination:

HYDROXYZINE

METHOD: 2440 , TESTIDCODE: 68005LCM56

Open Data Set

Plotted Points Statistics

HYDROXYZINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	34	68%	14%	66%	9%
Total	34	68%	14%	66%	9%

Sample Statistics

HYDROXYZINE

Characteristic	N	%	% Basis
Plotted	34	94%	Spiked
Estimated Values	6	17%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	36	.
False Negatives	2	6%	2 out of 36
Not Spiked	16	.
False Positives	0	0%	0 out of 16

BQS OBSP Determination:

IMINOSTILBENE

METHOD: 2440 , TESTIDCODE: 67481LCM56

Open Data Set

Plotted Points Statistics

IMINOSTILBENE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	33	83%	29%	85%	32%
Total	33	83%	29%	85%	32%

Sample Statistics

IMINOSTILBENE

Characteristic	N	%	% Basis
Plotted	33	100%	Spiked
Estimated Values	4	12%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	33	.
False Negatives	0	0%	0 out of 33
Not Spiked	19	.
False Positives	0	0%	0 out of 19

BQS OBSP Determination:

KETOCONAZOLE

METHOD: 2440 , TESTIDCODE: 68014LCM56

Open Data Set

Plotted Points Statistics

KETOCONAZOLE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	31	46%	18%	45%	21%
Total	31	46%	18%	45%	21%

Sample Statistics

KETOCONAZOLE

Characteristic	N	%	% Basis
Plotted	31	94%	Spiked
Estimated Values	13	39%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	33	.
False Negatives	2	6%	2 out of 33
Not Spiked	19	.
False Positives	0	0%	0 out of 19

BQS OBSP Determination:

LAMIVUDINE

METHOD: 2440 , TESTIDCODE: 68018LCM56

Open Data Set

Plotted Points Statistics

LAMIVUDINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	24	78%	40%	81%	33%
Total	24	78%	40%	81%	33%

Sample Statistics

LAMIVUDINE

Characteristic	N	%	% Basis
Plotted	24	67%	Spiked
Estimated Values	8	22%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	1	3%	Spiked
Spiked	36	.
False Negatives	11	31%	11 out of 36
Not Spiked	16	.
False Positives	0	0%	0 out of 16

BQS OBSP Determination:

LIDOCAINE

METHOD: 2440 , TESTIDCODE: 67462LCM56

Open Data Set

Plotted Points Statistics

LIDOCAINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	30	84%	15%	84%	11%
Total	30	84%	15%	84%	11%

Sample Statistics

LIDOCAINE

Characteristic	N	%	% Basis
Plotted	30	88%	Spiked
Estimated Values	2	6%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	4	12%	Spiked
Spiked	34	.
False Negatives	0	0%	0 out of 34
Not Spiked	18	.
False Positives	0	0%	0 out of 18

BQS OBSP Determination:

LOPERAMIDE

METHOD: 2440 , TESTIDCODE: 67515LCM56

Open Data Set

Plotted Points Statistics

LOPERAMIDE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	11	34%	13%	38%	13%
Total	11	34%	13%	38%	13%

Sample Statistics

LOPERAMIDE

Characteristic	N	%	% Basis
Plotted	11	52%	Spiked
Estimated Values	11	52%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	21	.
False Negatives	10	48%	10 out of 21
Not Spiked	31	.
False Positives	0	0%	0 out of 31

BQS OBSP Determination:

LORATADINE

METHOD: 2440 , TESTIDCODE: 67488LCM56

Open Data Set

Plotted Points Statistics

LORATADINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	35	45%	15%	47%	15%
Total	35	45%	15%	47%	15%

Sample Statistics

LORATADINE

Characteristic	N	%	% Basis
Plotted	35	100%	Spiked
Estimated Values	17	49%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	35	.
False Negatives	0	0%	0 out of 35
Not Spiked	17	.
False Positives	0	0%	0 out of 17

BQS OBSP Determination:

LORAZEPAM

METHOD: 2440 , TESTIDCODE: 67470LCM56

Open Data Set

Plotted Points Statistics

LORAZEPAM

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	16	93%	17%	92%	16%
Total	16	93%	17%	92%	16%

Sample Statistics

LORAZEPAM

Characteristic	N	%	% Basis
Plotted	16	89%	Spiked
Estimated Values	8	44%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	2	11%	Spiked
Spiked	18	.
False Negatives	0	0%	0 out of 18
Not Spiked	34	.
False Positives	0	0%	0 out of 34

BQS OBSP Determination:

MEPROBAMATE

METHOD: 2440 , TESTIDCODE: 67464LCM56

Open Data Set

Plotted Points Statistics

MEPROBAMATE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	19	85%	12%	85%	11%
Total	19	85%	12%	85%	11%

Sample Statistics

MEPROBAMATE

Characteristic	N	%	% Basis
Plotted	19	100%	Spiked
Estimated Values	4	21%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	19	.
False Negatives	0	0%	0 out of 19
Not Spiked	33	.
False Positives	0	0%	0 out of 33

BQS OBSP Determination:

METAXALONE

METHOD: 2440 , TESTIDCODE: 67504LCM56

Open Data Set

Plotted Points Statistics

METAXALONE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	31	68%	16%	69%	17%
Total	31	68%	16%	69%	17%

Sample Statistics

METAXALONE

Characteristic	N	%	% Basis
Plotted	31	91%	Spiked
Estimated Values	31	91%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	34	.
False Negatives	3	9%	3 out of 34
Not Spiked	18	.
False Positives	0	0%	0 out of 18

BQS OBSP Determination:

METFORMIN

METHOD: 2440 , TESTIDCODE: 67492LCM56

Open Data Set

Plotted Points Statistics

METFORMIN

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	33	59%	16%	55%	15%
Total	33	59%	16%	55%	15%

Sample Statistics

METFORMIN

Characteristic	N	%	% Basis
Plotted	33	97%	Spiked
Estimated Values	3	9%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	34	.
False Negatives	1	3%	1 out of 34
Not Spiked	18	.
False Positives	0	0%	0 out of 18

BQS OBSP Determination:

METHADONE

METHOD: 2440 , TESTIDCODE: 67500LCM56

Open Data Set

Plotted Points Statistics

METHADONE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	18	65%	20%	60%	9%
Total	18	65%	20%	60%	9%

Sample Statistics

METHADONE

Characteristic	N	%	% Basis
Plotted	18	90%	Spiked
Estimated Values	4	20%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	20	.
False Negatives	2	10%	2 out of 20
Not Spiked	32	.
False Positives	0	0%	0 out of 32

BQS OBSP Determination:

METHOCARBAMOL

METHOD: 2440 , TESTIDCODE: 67501LCM56

Open Data Set

Plotted Points Statistics

METHOCARBAMOL

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	30	77%	14%	76%	11%
Total	30	77%	14%	76%	11%

Sample Statistics

METHOCARBAMOL

Characteristic	N	%	% Basis
Plotted	30	88%	Spiked
Estimated Values	2	6%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	34	.
False Negatives	4	12%	4 out of 34
Not Spiked	18	.
False Positives	0	0%	0 out of 18

BQS OBSP Determination:

METHOTREXATE

METHOD: 2440 , TESTIDCODE: 67525LCM56

Open Data Set

Plotted Points Statistics

METHOTREXATE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	29	66%	15%	67%	16%
Total	29	66%	15%	67%	16%

Sample Statistics

METHOTREXATE

Characteristic	N	%	% Basis
Plotted	29	88%	Spiked
Estimated Values	29	88%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	33	.
False Negatives	4	12%	4 out of 33
Not Spiked	19	.
False Positives	0	0%	0 out of 19

BQS OBSP Determination:

METHYL-1H-BENZOTRIAZOLE

METHOD: 2440 , TESTIDCODE: 67514LCM56

Open Data Set

Plotted Points Statistics

METHYL-1H-BENZOTRIAZOLE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	35	86%	11%	85%	11%
Total	35	86%	11%	85%	11%

Sample Statistics

METHYL-1H-BENZOTRIAZOLE

Characteristic	N	%	% Basis
Plotted	35	100%	Spiked
Estimated Values	9	26%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	35	.
False Negatives	0	0%	0 out of 35
Not Spiked	17	.
False Positives	0	0%	0 out of 17

BQS OBSP Determination:

METOPROLOL

METHOD: 2440 , TESTIDCODE: 67523LCM56

Open Data Set

Plotted Points Statistics

METOPROLOL

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	32	35%	5%	35%	5%
Total	32	35%	5%	35%	5%

Sample Statistics

METOPROLOL

Characteristic	N	%	% Basis
Plotted	32	94%	Spiked
Estimated Values	3	9%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	1	3%	Spiked
Spiked	34	.
False Negatives	1	3%	1 out of 34
Not Spiked	18	.
False Positives	0	0%	0 out of 18

BQS OBSP Determination:

MORPHINE

METHOD: 2440 , TESTIDCODE: 67458LCM56

Open Data Set

Plotted Points Statistics

MORPHINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	14	71%	17%	70%	14%
Total	14	71%	17%	70%	14%

Sample Statistics

MORPHINE

Characteristic	N	%	% Basis
Plotted	14	70%	Spiked
Estimated Values	1	5%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	20	.
False Negatives	6	30%	6 out of 20
Not Spiked	32	.
False Positives	0	0%	0 out of 32

BQS OBSP Determination:

NADALOL

METHOD: 2440 , TESTIDCODE: 68006LCM56

Open Data Set

Plotted Points Statistics

NADALOL

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	36	76%	15%	72%	10%
Total	36	76%	15%	72%	10%

Sample Statistics

NADALOL

Characteristic	N	%	% Basis
Plotted	36	100%	Spiked
Estimated Values	2	6%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	36	.
False Negatives	0	0%	0 out of 36
Not Spiked	16	.
False Positives	0	0%	0 out of 16

BQS OBSP Determination:

NEVIRAPINE

METHOD: 2440 , TESTIDCODE: 68017LCM56

Open Data Set

Plotted Points Statistics

NEVIRAPINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	34	78%	15%	76%	13%
Total	34	78%	15%	76%	13%

Sample Statistics

NEVIRAPINE

Characteristic	N	%	% Basis
Plotted	34	100%	Spiked
Estimated Values	5	15%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	34	.
False Negatives	0	0%	0 out of 34
Not Spiked	18	.
False Positives	0	0%	0 out of 18

BQS OBSP Determination:

NICOTINE

METHOD: 2440 , TESTIDCODE: 67493LCM56

Open Data Set

Plotted Points Statistics

NICOTINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	36	60%	26%	56%	22%
Total	36	60%	26%	56%	22%

Sample Statistics

NICOTINE

Characteristic	N	%	% Basis
Plotted	36	97%	Spiked
Estimated Values	8	22%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	37	.
False Negatives	1	3%	1 out of 37
Not Spiked	15	.
False Positives	2	13%	2 out of 15

BQS OBSP Determination:

NIZATIDINE

METHOD: 2440 , TESTIDCODE: 67479LCM56

Open Data Set

Plotted Points Statistics

NIZATIDINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	14	44%	19%	42%	18%
Total	14	44%	19%	42%	18%

Sample Statistics

NIZATIDINE

Characteristic	N	%	% Basis
Plotted	14	39%	Spiked
Estimated Values	14	39%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	36	.
False Negatives	22	61%	22 out of 36
Not Spiked	16	.
False Positives	0	0%	0 out of 16

BQS OBSP Determination:

NORDIAZEPAM

METHOD: 2440 , TESTIDCODE: 68252LCM56

Open Data Set

Plotted Points Statistics

NORDIAZEPAM

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	19	82%	9%	82%	11%
Total	19	82%	9%	82%	11%

Sample Statistics

NORDIAZEPAM

Characteristic	N	%	% Basis
Plotted	19	100%	Spiked
Estimated Values	6	32%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	19	.
False Negatives	0	0%	0 out of 19
Not Spiked	33	.
False Positives	0	0%	0 out of 33

BQS OBSP Determination:

NORETHINDRONE

METHOD: 2440 , TESTIDCODE: 67434LCM56

Open Data Set

Plotted Points Statistics

NORETHINDRONE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	29	71%	19%	68%	12%
Total	29	71%	19%	68%	12%

Sample Statistics

NORETHINDRONE

Characteristic	N	%	% Basis
Plotted	29	85%	Spiked
Estimated Values	6	18%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	34	.
False Negatives	5	15%	5 out of 34
Not Spiked	18	.
False Positives	0	0%	0 out of 18

BQS OBSP Determination:

NORFLUOXETINE

METHOD: 2440 , TESTIDCODE: 67451LCM56

Open Data Set

Plotted Points Statistics

NORFLUOXETINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	36	64%	15%	63%	14%
Total	36	64%	15%	63%	14%

Sample Statistics

NORFLUOXETINE

Characteristic	N	%	% Basis
Plotted	36	100%	Spiked
Estimated Values	36	100%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	36	.
False Negatives	0	0%	0 out of 36
Not Spiked	16	.
False Positives	0	0%	0 out of 16

BQS OBSP Determination:

NORSERTRALINE

METHOD: 2440 , TESTIDCODE: 67532LCM56

Open Data Set

Plotted Points Statistics

NORSERTRALINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	5	62%	17%	54%	15%
Total	5	62%	17%	54%	15%

Sample Statistics

NORSERTRALINE

Characteristic	N	%	% Basis
Plotted	5	100%	Spiked
Estimated Values	5	100%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	5	.
False Negatives	0	0%	0 out of 5
Not Spiked	47	.
False Positives	0	0%	0 out of 47

BQS OBSP Determination:

NORVERAPAMIL

METHOD: 2440 , TESTIDCODE: 68007LCM56

Open Data Set

Plotted Points Statistics

NORVERAPAMIL

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	26	35%	14%	34%	15%
Total	26	35%	14%	34%	15%

Sample Statistics

NORVERAPAMIL

Characteristic	N	%	% Basis
Plotted	26	74%	Spiked
Estimated Values	26	74%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	35	.
False Negatives	9	26%	9 out of 35
Not Spiked	17	.
False Positives	0	0%	0 out of 17

BQS OBSP Determination:

OMEPRAZOLE + ESOMEPRAZOLE

METHOD: 2440 , TESTIDCODE: 67512LCM56

Open Data Set

Plotted Points Statistics

OMEPRAZOLE + ESOMEPRAZOLE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	5	22%	11%	26%	9%
Total	5	22%	11%	26%	9%

Sample Statistics

OMEPRAZOLE + ESOMEPRAZOLE

Characteristic	N	%	% Basis
Plotted	5	15%	Spiked
Estimated Values	1	3%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	2	6%	Spiked
Spiked	34	.
False Negatives	27	79%	27 out of 34
Not Spiked	18	.
False Positives	0	0%	0 out of 18

BQS OBSP Determination:

OSELTAMIVIR

METHOD: 2440 , TESTIDCODE: 67511LCM56

Open Data Set

Plotted Points Statistics

OSELTAMIVIR

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	19	49%	12%	51%	10%
Total	19	49%	12%	51%	10%

Sample Statistics

OSELTAMIVIR

Characteristic	N	%	% Basis
Plotted	19	90%	Spiked
Estimated Values	2	10%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	21	.
False Negatives	2	10%	2 out of 21
Not Spiked	31	.
False Positives	0	0%	0 out of 31

BQS OBSP Determination:

OXAZEPAM

METHOD: 2440 , TESTIDCODE: 67469LCM56

Open Data Set

Plotted Points Statistics

OXAZEPAM

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	16	57%	22%	51%	26%
Total	16	57%	22%	51%	26%

Sample Statistics

OXAZEPAM

Characteristic	N	%	% Basis
Plotted	16	76%	Spiked
Estimated Values	4	19%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	21	.
False Negatives	5	24%	5 out of 21
Not Spiked	31	.
False Positives	0	0%	0 out of 31

BQS OBSP Determination:

OXYCODONE

METHOD: 2440 , TESTIDCODE: 67495LCM56

Open Data Set

Plotted Points Statistics

OXYCODONE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	18	70%	12%	69%	13%
Total	18	70%	12%	69%	13%

Sample Statistics

OXYCODONE

Characteristic	N	%	% Basis
Plotted	18	95%	Spiked
Estimated Values	3	16%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	19	.
False Negatives	1	5%	1 out of 19
Not Spiked	33	.
False Positives	0	0%	0 out of 33

BQS OBSP Determination:

PAROXETINE

METHOD: 2440 , TESTIDCODE: 67527LCM56

Open Data Set

Plotted Points Statistics

PAROXETINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	30	43%	16%	43%	13%
Total	30	43%	16%	43%	13%

Sample Statistics

PAROXETINE

Characteristic	N	%	% Basis
Plotted	30	83%	Spiked
Estimated Values	30	83%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	36	.
False Negatives	6	17%	6 out of 36
Not Spiked	16	.
False Positives	0	0%	0 out of 16

BQS OBSP Determination:

PENCICLOVIR

METHOD: 2440 , TESTIDCODE: 68021LCM56

Open Data Set

Plotted Points Statistics

PENCICLOVIR

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	30	98%	26%	105%	37%
Total	30	98%	26%	105%	37%

Sample Statistics

PENCICLOVIR

Characteristic	N	%	% Basis
Plotted	30	88%	Spiked
Estimated Values	15	44%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	2	6%	Spiked
Spiked	34	.
False Negatives	2	6%	2 out of 34
Not Spiked	18	.
False Positives	0	0%	0 out of 18

BQS OBSP Determination:

PENTOXIFYLLINE

METHOD: 2440 , TESTIDCODE: 67480LCM56

Open Data Set

Plotted Points Statistics

PENTOXIFYLLINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	31	68%	17%	68%	24%
Total	31	68%	17%	68%	24%

Sample Statistics

PENTOXIFYLLINE

Characteristic	N	%	% Basis
Plotted	31	86%	Spiked
Estimated Values	8	22%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	1	3%	Spiked
Spiked	36	.
False Negatives	4	11%	4 out of 36
Not Spiked	16	.
False Positives	0	0%	0 out of 16

BQS OBSP Determination:

PHENAZOPYRIDINE

METHOD: 2440 , TESTIDCODE: 68008LCM56

Open Data Set

Plotted Points Statistics

PHENAZOPYRIDINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	36	83%	18%	79%	10%
Total	36	83%	18%	79%	10%

Sample Statistics

PHENAZOPYRIDINE

Characteristic	N	%	% Basis
Plotted	36	100%	Spiked
Estimated Values	12	33%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	36	.
False Negatives	0	0%	0 out of 36
Not Spiked	16	.
False Positives	0	0%	0 out of 16

BQS OBSP Determination:

PHENDIMETRAZINE

METHOD: 2440 , TESTIDCODE: 67496LCM56

Open Data Set

Sample Statistics

PHENDIMETRAZINE

Characteristic	N	%	% Basis
Plotted	0	.	Spiked
Estimated Values	0	.	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	.	Spiked
Spiked	0	.
False Negatives	0	.	0 out of 0
Not Spiked	52	.
False Positives	0	0%	0 out of 52

BQS OBSP Determination:

PHENYTOIN

METHOD: 2440 , TESTIDCODE: 67466LCM56

Open Data Set

Plotted Points Statistics

PHENYTOIN

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	34	83%	11%	82%	10%
Total	34	83%	11%	82%	10%

Sample Statistics

PHENYTOIN

Characteristic	N	%	% Basis
Plotted	34	97%	Spiked
Estimated Values	3	9%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	35	.
False Negatives	1	3%	1 out of 35
Not Spiked	17	.
False Positives	0	0%	0 out of 17

BQS OBSP Determination:

PIPERONYL BUTOXIDE

METHOD: 2440 , TESTIDCODE: 67435LCM56

Open Data Set

Plotted Points Statistics

PIPERONYL BUTOXIDE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	32	51%	23%	52%	21%
Total	32	51%	23%	52%	21%

Sample Statistics

PIPERONYL BUTOXIDE

Characteristic	N	%	% Basis
Plotted	32	89%	Spiked
Estimated Values	13	36%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	36	.
False Negatives	4	11%	4 out of 36
Not Spiked	16	.
False Positives	0	0%	0 out of 16

BQS OBSP Determination:

PREDNISOLONE

METHOD: 2440 , TESTIDCODE: 67483LCM56

Open Data Set

Plotted Points Statistics

PREDNISOLONE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	33	77%	10%	74%	11%
Total	33	77%	10%	74%	11%

Sample Statistics

PREDNISOLONE

Characteristic	N	%	% Basis
Plotted	33	92%	Spiked
Estimated Values	10	28%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	36	.
False Negatives	3	8%	3 out of 36
Not Spiked	16	.
False Positives	0	0%	0 out of 16

BQS OBSP Determination:

PREDNISONE

METHOD: 2440 , TESTIDCODE: 67467LCM56

Open Data Set

Plotted Points Statistics

PREDNISONE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	33	85%	15%	85%	17%
Total	33	85%	15%	85%	17%

Sample Statistics

PREDNISONE

Characteristic	N	%	% Basis
Plotted	33	97%	Spiked
Estimated Values	7	21%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	34	.
False Negatives	1	3%	1 out of 34
Not Spiked	18	.
False Positives	0	0%	0 out of 18

BQS OBSP Determination:

PROMETHAZINE

METHOD: 2440 , TESTIDCODE: 67524LCM56

Open Data Set

Plotted Points Statistics

PROMETHAZINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	3	21%	9%	24%	12%
Total	3	21%	9%	24%	12%

Sample Statistics

PROMETHAZINE

Characteristic	N	%	% Basis
Plotted	3	8%	Spiked
Estimated Values	3	8%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	1	3%	Spiked
Spiked	36	.
False Negatives	32	89%	32 out of 36
Not Spiked	16	.
False Positives	0	0%	0 out of 16

BQS OBSP Determination:

PROPOXYPHENE

METHOD: 2440 , TESTIDCODE: 68009LCM56

Open Data Set

Plotted Points Statistics

PROPOXYPHENE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	22	67%	26%	59%	11%
Total	22	67%	26%	59%	11%

Sample Statistics

PROPOXYPHENE

Characteristic	N	%	% Basis
Plotted	22	96%	Spiked
Estimated Values	5	22%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	23	.
False Negatives	1	4%	1 out of 23
Not Spiked	29	.
False Positives	0	0%	0 out of 29

BQS OBSP Determination:

PROPRANOLOL

METHOD: 2440 , TESTIDCODE: 67516LCM56

Open Data Set

Plotted Points Statistics

PROPRANOLOL

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	34	67%	9%	65%	9%
Total	34	67%	9%	65%	9%

Sample Statistics

PROPRANOLOL

Characteristic	N	%	% Basis
Plotted	34	97%	Spiked
Estimated Values	2	6%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	35	.
False Negatives	1	3%	1 out of 35
Not Spiked	17	.
False Positives	0	0%	0 out of 17

BQS OBSP Determination:

PSEUDOEPHEDRINE

METHOD: 2440 , TESTIDCODE: 67460LCM56

Open Data Set

Plotted Points Statistics

PSEUDOEPHEDRINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	18	76%	10%	75%	9%
Total	18	76%	10%	75%	9%

Sample Statistics

PSEUDOEPHEDRINE

Characteristic	N	%	% Basis
Plotted	18	100%	Spiked
Estimated Values	1	6%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	18	.
False Negatives	0	0%	0 out of 18
Not Spiked	34	.
False Positives	0	0%	0 out of 34

BQS OBSP Determination:

QUININE

METHOD: 2440 , TESTIDCODE: 68011LCM56

Open Data Set

Plotted Points Statistics

QUININE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	33	67%	21%	63%	17%
Total	33	67%	21%	63%	17%

Sample Statistics

QUININE

Characteristic	N	%	% Basis
Plotted	33	97%	Spiked
Estimated Values	15	44%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	34	.
False Negatives	1	3%	1 out of 34
Not Spiked	18	.
False Positives	0	0%	0 out of 18

BQS OBSP Determination:

RALOXIFENE

METHOD: 2440 , TESTIDCODE: 67530LCM56

Open Data Set

Plotted Points Statistics

RALOXIFENE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	24	42%	30%	32%	29%
Total	24	42%	30%	32%	29%

Sample Statistics

RALOXIFENE

Characteristic	N	%	% Basis
Plotted	24	73%	Spiked
Estimated Values	24	73%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	33	.
False Negatives	9	27%	9 out of 33
Not Spiked	19	.
False Positives	0	0%	0 out of 19

BQS OBSP Determination:

RANITIDINE

METHOD: 2440 , TESTIDCODE: 67452LCM56

Open Data Set

Plotted Points Statistics

RANITIDINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	24	31%	17%	30%	19%
Total	24	31%	17%	30%	19%

Sample Statistics

RANITIDINE

Characteristic	N	%	% Basis
Plotted	24	71%	Spiked
Estimated Values	24	71%	Spiked
Deleted Values	1	2%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	35	.
False Negatives	10	29%	10 out of 34
Not Spiked	17	.
False Positives	0	0%	0 out of 17

BQS OBSP Determination:

SERTRALINE

METHOD: 2440 , TESTIDCODE: 67528LCM56

Open Data Set

Plotted Points Statistics

SERTRALINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	29	44%	12%	46%	8%
Total	29	44%	12%	46%	8%

Sample Statistics

SERTRALINE

Characteristic	N	%	% Basis
Plotted	29	85%	Spiked
Estimated Values	29	85%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	34	.
False Negatives	5	15%	5 out of 34
Not Spiked	18	.
False Positives	0	0%	0 out of 18

BQS OBSP Determination:

SITAGLIPTIN

METHOD: 2440 , TESTIDCODE: 67531LCM56

Open Data Set

Plotted Points Statistics

SITAGLIPTIN

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	31	71%	23%	70%	23%
Total	31	71%	23%	70%	23%

Sample Statistics

SITAGLIPTIN

Characteristic	N	%	% Basis
Plotted	31	100%	Spiked
Estimated Values	16	52%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	31	.
False Negatives	0	0%	0 out of 31
Not Spiked	21	.
False Positives	0	0%	0 out of 21

BQS OBSP Determination:

SULFADIMETHOXINE

METHOD: 2440 , TESTIDCODE: 67503LCM56

Open Data Set

Plotted Points Statistics

SULFADIMETHOXINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	35	76%	16%	77%	12%
Total	35	76%	16%	77%	12%

Sample Statistics

SULFADIMETHOXINE

Characteristic	N	%	% Basis
Plotted	35	100%	Spiked
Estimated Values	5	14%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	35	.
False Negatives	0	0%	0 out of 35
Not Spiked	17	.
False Positives	0	0%	0 out of 17

BQS OBSP Determination:

SULFAMETHIZOLE

METHOD: 2440 , TESTIDCODE: 67476LCM56

Open Data Set

Plotted Points Statistics

SULFAMETHIZOLE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	35	81%	12%	82%	11%
Total	35	81%	12%	82%	11%

Sample Statistics

SULFAMETHIZOLE

Characteristic	N	%	% Basis
Plotted	35	97%	Spiked
Estimated Values	1	3%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	36	.
False Negatives	1	3%	1 out of 36
Not Spiked	16	.
False Positives	0	0%	0 out of 16

BQS OBSP Determination:

SULFAMETHOXAZOLE

METHOD: 2440 , TESTIDCODE: 67454LCM56

Open Data Set

Plotted Points Statistics

SULFAMETHOXAZOLE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	34	81%	16%	83%	11%
Total	34	81%	16%	83%	11%

Sample Statistics

SULFAMETHOXAZOLE

Characteristic	N	%	% Basis
Plotted	34	100%	Spiked
Estimated Values	7	21%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	34	.
False Negatives	0	0%	0 out of 34
Not Spiked	18	.
False Positives	0	0%	0 out of 18

BQS OBSP Determination:

TAMOXIFEN

METHOD: 2440 , TESTIDCODE: 68015LCM56

Open Data Set

Plotted Points Statistics

TAMOXIFEN

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	2	16%	1%	16%	1%
Total	2	16%	1%	16%	1%

Sample Statistics

TAMOXIFEN

Characteristic	N	%	% Basis
Plotted	2	6%	Spiked
Estimated Values	2	6%	Spiked
Deleted Values	1	2%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	37	.
False Negatives	34	94%	34 out of 36
Not Spiked	15	.
False Positives	0	0%	0 out of 15

BQS OBSP Determination:

TEMAZEPAM

METHOD: 2440 , TESTIDCODE: 67471LCM56

Open Data Set

Plotted Points Statistics

TEMAZEPAM

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	18	66%	14%	67%	13%
Total	18	66%	14%	67%	13%

Sample Statistics

TEMAZEPAM

Characteristic	N	%	% Basis
Plotted	18	86%	Spiked
Estimated Values	2	10%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	1	5%	Spiked
Spiked	21	.
False Negatives	2	10%	2 out of 21
Not Spiked	31	.
False Positives	0	0%	0 out of 31

BQS OBSP Determination:

THEOPHYLLINE

METHOD: 2440 , TESTIDCODE: 67494LCM56

Open Data Set

Plotted Points Statistics

THEOPHYLLINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	26	87%	15%	84%	8%
Total	26	87%	15%	84%	8%

Sample Statistics

THEOPHYLLINE

Characteristic	N	%	% Basis
Plotted	26	76%	Spiked
Estimated Values	3	9%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	4	12%	Spiked
Spiked	34	.
False Negatives	4	12%	4 out of 34
Not Spiked	18	.
False Positives	0	0%	0 out of 18

BQS OBSP Determination:

THIABENDAZOLE

METHOD: 2440 , TESTIDCODE: 67455LCM56

Open Data Set

Plotted Points Statistics

THIABENDAZOLE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	24	72%	25%	71%	24%
Total	24	72%	25%	71%	24%

Sample Statistics

THIABENDAZOLE

Characteristic	N	%	% Basis
Plotted	24	73%	Spiked
Estimated Values	8	24%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	33	.
False Negatives	9	27%	9 out of 33
Not Spiked	19	.
False Positives	0	0%	0 out of 19

BQS OBSP Determination:

TIOTROPIUM

METHOD: 2440 , TESTIDCODE: 67508LCM56

Open Data Set

Plotted Points Statistics

TIOTROPIUM

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	15	42%	37%	34%	27%
Total	15	42%	37%	34%	27%

Sample Statistics

TIOTROPIUM

Characteristic	N	%	% Basis
Plotted	15	75%	Spiked
Estimated Values	15	75%	Spiked
Deleted Values	1	2%	Spiked + Not Spiked
Spiked, Censored	1	5%	Spiked
Spiked	20	.
False Negatives	4	20%	4 out of 20
Not Spiked	32	.
False Positives	0	0%	0 out of 31

BQS OBSP Determination:

TRAMADOL

METHOD: 2440 , TESTIDCODE: 67517LCM56

Open Data Set

Plotted Points Statistics

TRAMADOL

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	31	74%	11%	72%	11%
Total	31	74%	11%	72%	11%

Sample Statistics

TRAMADOL

Characteristic	N	%	% Basis
Plotted	31	100%	Spiked
Estimated Values	2	6%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	31	.
False Negatives	0	0%	0 out of 31
Not Spiked	21	.
False Positives	0	0%	0 out of 21

BQS OBSP Determination:

TRIAMTERENE

METHOD: 2440 , TESTIDCODE: 67475LCM56

Open Data Set

Plotted Points Statistics

TRIAMTERENE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	33	77%	17%	78%	17%
Total	33	77%	17%	78%	17%

Sample Statistics

TRIAMTERENE

Characteristic	N	%	% Basis
Plotted	33	100%	Spiked
Estimated Values	10	30%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	33	.
False Negatives	0	0%	0 out of 33
Not Spiked	19	.
False Positives	0	0%	0 out of 19

BQS OBSP Determination:

TRIMETHOPRIM

METHOD: 2440 , TESTIDCODE: 67456LCM56

Open Data Set

Plotted Points Statistics

TRIMETHOPRIM

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	32	90%	24%	94%	23%
Total	32	90%	24%	94%	23%

Sample Statistics

TRIMETHOPRIM

Characteristic	N	%	% Basis
Plotted	32	97%	Spiked
Estimated Values	8	24%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	33	.
False Negatives	1	3%	1 out of 33
Not Spiked	19	.
False Positives	0	0%	0 out of 19

BQS OBSP Determination:

VALACYCLOVIR

METHOD: 2440 , TESTIDCODE: 67507LCM56

Open Data Set

Plotted Points Statistics

VALACYCLOVIR

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	33	33%	21%	37%	21%
Total	33	33%	21%	37%	21%

Sample Statistics

VALACYCLOVIR

Characteristic	N	%	% Basis
Plotted	33	100%	Spiked
Estimated Values	33	100%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	33	.
False Negatives	0	0%	0 out of 33
Not Spiked	19	.
False Positives	0	0%	0 out of 19

BQS OBSP Determination:

VENLAFAXINE

METHOD: 2440 , TESTIDCODE: 67534LCM56

Open Data Set

Plotted Points Statistics

VENLAFAXINE

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	30	65%	14%	64%	15%
Total	30	65%	14%	64%	15%

Sample Statistics

VENLAFAXINE

Characteristic	N	%	% Basis
Plotted	30	88%	Spiked
Estimated Values	1	3%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	34	.
False Negatives	4	12%	4 out of 34
Not Spiked	18	.
False Positives	0	0%	0 out of 18

BQS OBSP Determination:

VERAPAMIL

METHOD: 2440 , TESTIDCODE: 67472LCM56

Open Data Set

Plotted Points Statistics

VERAPAMIL

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	28	29%	13%	27%	13%
Total	28	29%	13%	27%	13%

Sample Statistics

VERAPAMIL

Characteristic	N	%	% Basis
Plotted	28	80%	Spiked
Estimated Values	5	14%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	35	.
False Negatives	7	20%	7 out of 35
Not Spiked	17	.
False Positives	0	0%	0 out of 17

BQS OBSP Determination:

WARFARIN

METHOD: 2440 , TESTIDCODE: 67457LCM56

Open Data Set

Plotted Points Statistics

WARFARIN

Spike Level	N	Mean	Std-Dev.	Median	F_Pseudo
>= Reporting Level	32	57%	19%	55%	20%
Total	32	57%	19%	55%	20%

Sample Statistics

WARFARIN

Characteristic	N	%	% Basis
Plotted	32	94%	Spiked
Estimated Values	9	26%	Spiked
Deleted Values	0	0%	Spiked + Not Spiked
Spiked, Censored	0	0%	Spiked
Spiked	34	.
False Negatives	2	6%	2 out of 34
Not Spiked	18	.
False Positives	0	0%	0 out of 18